Gallant Elevates Veterinary Affairs Leadership in Regenerative Pet Therapies

According to a recent LinkedIn post from Gallant, the company is highlighting an internal leadership change with the promotion of Rebecca Windsor, DVM, DACVIM, to Vice President of Veterinary Affairs. The post portrays Windsor as having built and led the veterinary affairs function over the past year with emphasis on strategic planning, scientific rigor, and communication skills.

The post suggests that this leadership role is central to advancing Gallant’s work in regenerative therapies for pets and in building trust and accessibility around its scientific offerings. For investors, the elevation of a clinically credentialed leader to a senior role could indicate continued focus on evidence-based product development, regulatory readiness, and professional outreach, which may strengthen Gallant’s positioning in the veterinary medicine and animal health markets.